Group One Trading, L.P. X4 Pharmaceuticals, Inc Transaction History

Group One Trading, L.P.

$2.4 Billion
Q3 2024

A detailed history of Group One Trading, L.P. transactions in X4 Pharmaceuticals, Inc stock. As of the latest transaction made, Group One Trading, L.P. holds 125,504 shares of XFOR stock, worth $60,241. This represents 0.0% of its overall portfolio holdings.

Number of Shares

125,504

Previous 164,248 23.59%

Holding current value

$60,241

Previous $95,000 11.58%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.54 - $0.86 $20,921 - $33,319	-38,744 Reduced 23.59%	125,504 $84,000
Q2 2024 Aug 14, 2024	BUY	$0.58 - $1.47 $82,941 - $210,212	143,002 Added 673.08%	164,248 $95,000
Q1 2024 May 10, 2024	SELL	$0.72 - $1.46 $35,652 - $72,296	-49,518 Reduced 69.98%	21,246 $29,000
Q4 2023 Feb 14, 2024	SELL	$0.61 - $0.99 $94,914 - $154,041	-155,597 Reduced 68.74%	70,764 $59,000
Q3 2023 Nov 09, 2023	SELL	$1.03 - $2.02 $102,547 - $201,113	-99,561 Reduced 30.55%	226,361 $246,000
Q2 2023 Aug 09, 2023	BUY	$0.82 - $2.49 $242,403 - $736,078	295,614 Added 975.37%	325,922 $632,000
Q1 2023 May 12, 2023	BUY	$0.8 - $1.22 $8,102 - $12,356	10,128 Added 50.19%	30,308 $26,000
Q4 2022 Feb 09, 2023	SELL	$0.69 - $2.21 $8,760 - $28,058	-12,696 Reduced 38.62%	20,180 $19,000
Q3 2022 Nov 09, 2022	BUY	$0.89 - $1.71 $29,259 - $56,217	32,876 New	32,876 $56,000
Q2 2022 Aug 11, 2022	SELL	$0.88 - $1.91 $14,916 - $32,374	-16,950 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$1.48 - $2.58 $4,736 - $8,256	3,200 Added 23.27%	16,950 $30,000
Q4 2021 Feb 11, 2022	BUY	$1.9 - $5.6 $22,167 - $65,335	11,667 Added 560.11%	13,750 $31,000
Q3 2021 Nov 12, 2021	BUY	$4.53 - $6.45 $9,435 - $13,435	2,083 New	2,083 $11,000

Others Institutions Holding XFOR

# of Institutions

103

Shares Held

100M

Call Options Held

213K

Put Options Held

50.6K

View Full List

About X4 Pharmaceuticals, Inc

Ticker XFOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,646,096
Market Cap $33M
Description
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...

More about XFOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. X4 Pharmaceuticals, Inc Transaction History